Related Experiment Video
Updated: Sep 6, 2025

Mapping Alzheimer's Disease Variants to Their Target Genes Using Computational Analysis of Chromatin Configuration
Published on: January 9, 2020
Functional associations between polymorphic regions of the human 3'IgH locus and COVID-19 disease
Mattia Colucci1, Domenico Frezza2, Giovanni Gambassi3
1Institute for Stem Cell Biology, Regenerative Medicine and Innovative Therapies (ISBReMIT), Fondazione IRCCS Casa Sollievo della Sofferenza, Viale Padre Pio, 7, San Giovanni Rotondo 71013, Italy.
Insights
Genetic variants in COVID-19 patients impact disease severity. A specific allele, enriched in women, may explain sex differences in immune response to SARS-CoV-2 infection.
Area of Science:
- Immunogenetics
- COVID-19 Research
- Human Genetics
Background:
- Coronavirus Disease 2019 (COVID-19) exhibits notable gender-based differences in severity.
- The influence of genetic background on COVID-19 clinical outcomes is not well understood.
Purpose of the Study:
- To investigate the association between genetic variations and COVID-19 severity.
- To identify potential genetic factors contributing to sex-related differences in disease outcomes.
Main Methods:
- Blood samples from 192 COVID-19 patients (115 men, 77 women) were analyzed.
- Allelic distribution of nine Single Nucleotide Polymorphisms (SNPs) in the immunoglobulin heavy chain locus (3'RR-1) was determined.
Main Results:
- Seven specific haplotypes were identified, linked to varying disease severity and pneumonia occurrence.
- The *2 allele, containing an Estrogen receptor alpha (ERα) binding site, was more frequent in women with milder COVID-19.
Conclusions:
- Genetic variants are associated with individual clinical severity in COVID-19.
- A novel genetic protective factor may explain sex-based differences in SARS-CoV-2 immune response.
Purpose:
The pandemic diffusion of Coronavirus Disease 2019 (COVID-19) has highlighted significant gender-related differences in disease severity. Despite several hypotheses being proposed, how the genetic background of COVID-19 patients might impact clinical outcomes remains largely unknown.
Methods:
We collected blood samples from 192 COVID-19 patients (115 men, 77 women, mean age 67 ± 19 years) admitted between March and June 2020 at two different hospital centers in Italy, and determined the allelic distribution of nine Single Nucleotide Polymorphisms (SNPs), located at the 3'Regulatory Region (3'RR)-1 in the immunoglobulin (Ig) heavy chain locus, including *1 and *2 alleles of polymorphic hs1.2 enhancer region.
Results:
In COVID-19 patients, the genotyped SNPs exhibited strong Linkage Disequilibrium and produced 7 specific haplotypes, associated to different degrees of disease severity, including the occurrence of pneumonia. Additionally, the allele *2, which comprises a DNA binding site for the Estrogen receptor alpha (ERα) in the polymorphic enhancer hs1.2 of 3'RR-1, was significantly enriched in women with a less severe disease.
Conclusions:
These findings document genetic variants associated to individual clinical severity of COVID-19 disease. Most specifically, a novel genetic protective factor was identified that might explain the sex-related differences in immune response to Sars-COV-2 infection in humans.
More Related Videos
11:35Screening for Functional Non-coding Genetic Variants Using Electrophoretic Mobility Shift Assay EMSA and DNA-affinity Precipitation Assay DAPA
Published on: August 21, 2016
07:26High-resolution Melting PCR for Complement Receptor 1 Length Polymorphism Genotyping: An Innovative Tool for Alzheimer's Disease Gene Susceptibility Assessment
Published on: July 18, 2017
Related Concept Videos
Single Nucleotide Polymorphisms-SNPs
Genome-wide Association Studies-GWAS
GWAS does not require the identification of the target gene involved in...
Human Genetics
The complex relationship between genetics and psychology is observable through common biological components such...
Exon Recombination
Exon shuffling follows “splice frame rules.” Each exon...
Viral Recombination